Home/Filings/4/0001628908-24-000098
4//SEC Filing

Weinberg Jonathan 4

Accession 0001628908-24-000098

CIK 0001628908other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 8:14 PM ET

Size

13.7 KB

Accession

0001628908-24-000098

Insider Transaction Report

Form 4
Period: 2024-08-22
Weinberg Jonathan
General Counsel
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-08-22$13.95/sh+25,253$352,279192,280 total
  • Sale

    Class A Common Stock

    2024-08-22$30.00/sh16,887$506,610167,027 total
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2024-08-2225,2530 total
    Exercise: $13.95Exp: 2028-02-01Class A Common Stock (25,253 underlying)
  • Sale

    Class A Common Stock

    2024-08-22$32.00/sh25,253$808,096167,027 total
  • Exercise/Conversion

    Class A Common Stock

    2024-08-22$17.00/sh+16,887$287,079183,914 total
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2024-08-2216,8870 total
    Exercise: $17.00Exp: 2025-06-04Class A Common Stock (16,887 underlying)
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F3]The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020, February 1, 2021, and February 1, 2022.
  • [F4]The Class A Common Stock Options exercised vested on June 4, 2016, June 4, 2017, June 4, 2018, and June 4, 2019.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001642833

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 8:14 PM ET
Size
13.7 KB